Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Investigators at University of Pennsylvania, Medical Department release new data on immunization
March 11th, 2009
In this recent report, researchers in the United States conducted a study "Toll-like receptors contribute to the establishment of adaptive immune responses. The reported studies were conducted to examine the effects of the Toll-like receptor (TLR)-7 ligand, resiquimod, on human naive B-cell differentiation." "Naive human B cells were cultured with resiquimod in the presence or absence of IL-2 and IL-10. Secreted IgM and IgG were measured by ELISA, and IL-6, IL-10, and IFN-alpha were measured by a multiplex protein array. Cell proliferation was assessed by measuring [3 H]thymidine uptake. mRNA for activation-induced cytidine deaminase and I-gamma 1-C-mu circle...
Source: Vaccine Weekly (2009-03-11)
|
